Topical 2: Discover, Development and Delivery of Medicines | |||
| Session 348 - Innovations in Biopharmaceutical Development: Fast to Market, Short on Time I | |||
| Innovations in the lab, pilot plant and work processes that result in higher productivity and faster work processes will be the focus of the session. | |||
| Chair: | Shih-Hsie Pan | ||
| CoChair: | Gregory Frank | ||
| CoSponsor(s): | Technology Transfer Pharmaceuticals (See also Topical 2) | ||
| 348a | Improving Pharmaceutical Product Development and Manufacturing: Impact on Cost of Goods Sold of Pharmaceuticals and Cost of New Drug Development Pradeep Suresh, Prabir K. Basu, Venkat Venkatasubramanian | ||
| 348b | Risk Management in the Development of Novel Biomedical Devices and Vaccines Miguel J. Bagajewicz, Victoria Froude, Emily Burdett, Mark C. Shreve, Erica Clemente-Harl, Melissa L. Martin, Vassilios I. Sikavitsas | ||
| 348c | High Throughput Cell Culture Development Using the Simcell Platform A. Peter Russo | ||
| 348d | A Systematic Protein Purification Process Synthesis Strategy Beckley K. Nfor, Tangir Ahamed, Marcel Ottens, Emile J. A. X. van de Sandt, Michel Eppink, Gijs W. K. van Dedem, Luuk A. M. van der Wielen | ||
| 348e | A Case Study: Utilization of Antibody Purification Platforms - Impact on Timelines Nihal Tugcu, David J. Roush, Kent E. Goklen | ||
| 348f | Large-Scale Pool-Less Purification Joseph E. Shultz, Samuel Yeboah, Roger A. Hart, John R. Ogez | ||
| 348g | Regulated Production of Biologically Active Insulin from Engineered Human Skin Substitutes for Treatment of Diabetes Pedro Lei, Jun Tian, Stelios T. Andreadis | ||
See more of Topical 2: Discovery, Development and Delivery of Medicines